Form 8-K - Current report:
SEC Accession No. 0001193125-24-198866
Filing Date
2024-08-12
Accepted
2024-08-12 16:05:54
Documents
17
Period of Report
2024-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d803822d8k.htm   iXBRL 8-K 53043
2 EX-10.1 d803822dex101.htm EX-10.1 113685
3 EX-10.2 d803822dex102.htm EX-10.2 114917
4 EX-99.1 d803822dex991.htm EX-99.1 10424
8 GRAPHIC g803822dsp75.jpg GRAPHIC 14716
  Complete submission text file 0001193125-24-198866.txt   509481

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bior-20240812.xsd EX-101.SCH 2869
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20240812_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20240812_pre.xml EX-101.PRE 11720
19 EXTRACTED XBRL INSTANCE DOCUMENT d803822d8k_htm.xml XML 3778
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241196750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)